Bendinelli M, Toniolo A, Matteucci D, Celeste F, Revoltella R
J Gen Virol. 1980 Feb;46(2):311-24. doi: 10.1099/0022-1317-46-2-311.
Fresh human sera neutralize Friend leukaemia virus (FLV). The activity is abolished by heating (56 degrees C for 30 min), hydrazine and EDTA treatment, suggesting the involvement of complement. Human sera also contain antibody which specifically reacts with FLV. Following incubation with human whole serum, IgG and F(ab')2 fragments, FLV acquire the ability to bind anti-human Ig sera, as shown in neutralization and radioimmunoprecipitation assay. The same is true for FLV-infected cells but not for uninfected control cells, as assessed by immunofluorescence. The binding of antibody to FLV-infected cells is prevented by pre-treating the cells with antisera to FLV and FLV-gp71, and is completed by FLV, FLV-gp71 and, to a lesser extent, by FLV-p12 and p30.
新鲜人血清能中和弗氏白血病病毒(FLV)。加热(56℃ 30分钟)、肼和乙二胺四乙酸(EDTA)处理会使该活性丧失,提示补体参与其中。人血清中还含有能与FLV特异性反应的抗体。如在中和及放射免疫沉淀试验中所示,与人类全血清、免疫球蛋白G(IgG)和F(ab')2片段孵育后,FLV获得了结合抗人免疫球蛋白血清的能力。通过免疫荧光评估,对于感染FLV的细胞也是如此,但未感染的对照细胞则不然。用抗FLV和FLV - gp71抗血清预处理细胞可阻止抗体与感染FLV的细胞结合,而FLV、FLV - gp71以及在较小程度上,FLV - p12和p30可使这种结合完成。